HIV Vaccine Info-line

Readability and Accessibility tools for the visually impaired


Background and establishment of SAAVI

The South African AIDS Vaccine Initiative (SAAVI) was established in 1999 as an initiative of the South African government and is a lead programme of the South African Medical Research Council (MRC). SAAVI co-ordinates and supports the development and testing of HIV vaccines in South Africa with the aim to find an affordable, effective and locally relevant HIV vaccine. SAAVI works with local and international partners to achieve the common aim of finding a successful HIV vaccine.

SAAVI has received direct funding from the South African Departments of Health [to date] and Science & Technology [up to 2008], ESKOM [up to end 2007] and the Impala Platinum Community Development Trust [up to June 2009], Transnet and the European Commission (EC) [up to September 2006] .

A new agreement for the period 2009-2012 has been signed between the National Department of Health (NDOH) and the MRC-SAAVI. In addition SAAVI currently receives funding from the Italian Ministry of Foreign Affairs, Directorate General of Development Cooperation (MAE-DGCS) for its role in the ‘Program to support the Ministry of Health of South Africa in the implementation of a national program of global response to HIV & AIDS’, a joint development cooperation between the governments of Italy and South Africa. The Program is implemented by the National Institute of Health of Italy (Istituto Superiore di Sanita’ or ISS) in cooperation with the South African NDOH supported by SAAVI.

Press releases

Questions and Answers - ISS T-003 Therapeutic HIV Vaccine Clinical Trial, pdf format, 366 kb (19 April 2011)

SAAVI is financially supported by

SA Medical Research Council
South African Department of Health
Italian Co operation
Istituto Superiore di Sanità
Last updated: 20-Nov-2015